Eszopiclone Tablets
intended to alleviate insomnia symptoms indicated to support sleep patterns.
Strengths: 1 · 2 · 3mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Lunesta
- Therapeutic class
Non-benzodiazepine Hypnotic
- Pharmacological class
Cyclopyrrolone
- Contraindications
hypersensitivity; severe hepatic impairment; severe sleep apnoea
- Precautions and warnings
may cause residual morning grogginess; dependence may develop with prolonged use
- Minor side effects
unpleasant taste; headache; somnolence
- Moderate side effects
dizziness; dry mouth; anxiety
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
intended to alleviate insomnia symptoms indicated to support sleep patterns.
- Prescription status
POM
- Onset Time
30–60 minutes
- Duration
6–8 hours
- Storage instructions
Store at room temperature away from moisture.
- Drug interactions
alcohol; CNS depressants; ketoconazole
- Age restrictions
Not recommended for children.
- Pregnancy and breastfeeding
Use only if benefit outweighs risk.
Serious side effects
complex sleep behaviours — requires immediate medical attention; hallucinations — requires immediate medical attention
Mechanism of action
Eszopiclone is a non-benzodiazepine hypnotic that acts on the GABA-A receptor complex, enhancing the inhibitory effects of neurotransmitters in the central nervous system to induce sleep.
Eszopiclone Tablets
intended to alleviate insomnia symptoms indicated to support sleep patterns.
Editorial Notes
- Active ingredient(s): Eszopiclone
- Listed indication(s): Insomnia